カテゴリー： Market Monitor Global, 世界, 医療/バイオ

インフルエンザ予防接種の世界市場見通し2023年-2029年

◆英語タイトル：Flu Vaccination Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5566）◆商品コード：MMG23JU5566
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：73
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Flu Vaccination Market 調査レポートは次の情報を含め、グローバルにおけるのインフルエンザ予防接種市場規模と予測を収録しています。・世界のインフルエンザ予防接種市場：売上、2018年-2023年、2024年-2029年
・世界のインフルエンザ予防接種市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のインフルエンザ予防接種市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「3価インフルエンザワクチン」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

インフルエンザ予防接種のグローバル主要企業は、Sanofi、 CSL、 GSK、 Viatris、 AstraZeneca、 Hualan Bio、 Changchun Institute of Biological、 Sinovac、 BCHT、 Jiangsu GDK、 KM Biologicsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、インフルエンザ予防接種のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のインフルエンザ予防接種市場：タイプ別、2018年-2023年、2024年-2029年
世界のインフルエンザ予防接種市場：タイプ別市場シェア、2022年
・3価インフルエンザワクチン、4価インフルエンザワクチン

世界のインフルエンザ予防接種市場：用途別、2018年-2023年、2024年-2029年
世界のインフルエンザ予防接種市場：用途別市場シェア、2022年
・6か月～3年、3年以上

世界のインフルエンザ予防接種市場：地域・国別、2018年-2023年、2024年-2029年
世界のインフルエンザ予防接種市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるインフルエンザ予防接種のグローバル売上、2018年-2023年
・主要企業におけるインフルエンザ予防接種のグローバル売上シェア、2022年
・主要企業におけるインフルエンザ予防接種のグローバル販売量、2018年-2023年
・主要企業におけるインフルエンザ予防接種のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Sanofi、 CSL、 GSK、 Viatris、 AstraZeneca、 Hualan Bio、 Changchun Institute of Biological、 Sinovac、 BCHT、 Jiangsu GDK、 KM Biologics

*************************************************************

・調査・分析レポートの概要
インフルエンザ予防接種市場の定義
市場セグメント
世界のインフルエンザ予防接種市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のインフルエンザ予防接種市場規模
世界のインフルエンザ予防接種市場規模：2022年 VS 2029年
世界のインフルエンザ予防接種市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのインフルエンザ予防接種の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のインフルエンザ予防接種製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：3価インフルエンザワクチン、4価インフルエンザワクチン
インフルエンザ予防接種のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：6か月～3年、3年以上
インフルエンザ予防接種の用途別グローバル売上・予測

・地域別市場分析
地域別インフルエンザ予防接種市場規模 2022年と2029年
地域別インフルエンザ予防接種売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Sanofi、 CSL、 GSK、 Viatris、 AstraZeneca、 Hualan Bio、 Changchun Institute of Biological、 Sinovac、 BCHT、 Jiangsu GDK、 KM Biologics
...

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
This report aims to provide a comprehensive presentation of the global market for Flu Vaccination, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flu Vaccination. This report contains market size and forecasts of Flu Vaccination in global, including the following market information:
Global Flu Vaccination Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Flu Vaccination Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Flu Vaccination companies in 2022 (%)
The global Flu Vaccination market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Trivalent Influenza Vaccine Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Flu Vaccination include Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac and BCHT, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Flu Vaccination manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Flu Vaccination Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Flu Vaccination Market Segment Percentages, by Type, 2022 (%)
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Global Flu Vaccination Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Flu Vaccination Market Segment Percentages, by Application, 2022 (%)
6 Months to 3 Years
Above 3 Years
Global Flu Vaccination Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Flu Vaccination Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Flu Vaccination revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Flu Vaccination revenues share in global market, 2022 (%)
Key companies Flu Vaccination sales in global market, 2018-2023 (Estimated), (Units)
Key companies Flu Vaccination sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Flu Vaccination, market overview.
Chapter 2: Global Flu Vaccination market size in revenue and volume.
Chapter 3: Detailed analysis of Flu Vaccination manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Flu Vaccination in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Flu Vaccination capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Flu Vaccination Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Flu Vaccination Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Flu Vaccination Overall Market Size
2.1 Global Flu Vaccination Market Size: 2022 VS 2029
2.2 Global Flu Vaccination Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Flu Vaccination Sales: 2018-2029
3 Company Landscape
3.1 Top Flu Vaccination Players in Global Market
3.2 Top Global Flu Vaccination Companies Ranked by Revenue
3.3 Global Flu Vaccination Revenue by Companies
3.4 Global Flu Vaccination Sales by Companies
3.5 Global Flu Vaccination Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Flu Vaccination Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Flu Vaccination Product Type
3.8 Tier 1, Tier 2 and Tier 3 Flu Vaccination Players in Global Market
3.8.1 List of Global Tier 1 Flu Vaccination Companies
3.8.2 List of Global Tier 2 and Tier 3 Flu Vaccination Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Flu Vaccination Market Size Markets, 2022 & 2029
4.1.2 Trivalent Influenza Vaccine
4.1.3 Quadrivalent Influenza Vaccine
4.2 By Type – Global Flu Vaccination Revenue & Forecasts
4.2.1 By Type – Global Flu Vaccination Revenue, 2018-2023
4.2.2 By Type – Global Flu Vaccination Revenue, 2024-2029
4.2.3 By Type – Global Flu Vaccination Revenue Market Share, 2018-2029
4.3 By Type – Global Flu Vaccination Sales & Forecasts
4.3.1 By Type – Global Flu Vaccination Sales, 2018-2023
4.3.2 By Type – Global Flu Vaccination Sales, 2024-2029
4.3.3 By Type – Global Flu Vaccination Sales Market Share, 2018-2029
4.4 By Type – Global Flu Vaccination Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Flu Vaccination Market Size, 2022 & 2029
5.1.2 6 Months to 3 Years
5.1.3 Above 3 Years
5.2 By Application – Global Flu Vaccination Revenue & Forecasts
5.2.1 By Application – Global Flu Vaccination Revenue, 2018-2023
5.2.2 By Application – Global Flu Vaccination Revenue, 2024-2029
5.2.3 By Application – Global Flu Vaccination Revenue Market Share, 2018-2029
5.3 By Application – Global Flu Vaccination Sales & Forecasts
5.3.1 By Application – Global Flu Vaccination Sales, 2018-2023
5.3.2 By Application – Global Flu Vaccination Sales, 2024-2029
5.3.3 By Application – Global Flu Vaccination Sales Market Share, 2018-2029
5.4 By Application – Global Flu Vaccination Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Flu Vaccination Market Size, 2022 & 2029
6.2 By Region – Global Flu Vaccination Revenue & Forecasts
6.2.1 By Region – Global Flu Vaccination Revenue, 2018-2023
6.2.2 By Region – Global Flu Vaccination Revenue, 2024-2029
6.2.3 By Region – Global Flu Vaccination Revenue Market Share, 2018-2029
6.3 By Region – Global Flu Vaccination Sales & Forecasts
6.3.1 By Region – Global Flu Vaccination Sales, 2018-2023
6.3.2 By Region – Global Flu Vaccination Sales, 2024-2029
6.3.3 By Region – Global Flu Vaccination Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Flu Vaccination Revenue, 2018-2029
6.4.2 By Country – North America Flu Vaccination Sales, 2018-2029
6.4.3 US Flu Vaccination Market Size, 2018-2029
6.4.4 Canada Flu Vaccination Market Size, 2018-2029
6.4.5 Mexico Flu Vaccination Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Flu Vaccination Revenue, 2018-2029
6.5.2 By Country – Europe Flu Vaccination Sales, 2018-2029
6.5.3 Germany Flu Vaccination Market Size, 2018-2029
6.5.4 France Flu Vaccination Market Size, 2018-2029
6.5.5 U.K. Flu Vaccination Market Size, 2018-2029
6.5.6 Italy Flu Vaccination Market Size, 2018-2029
6.5.7 Russia Flu Vaccination Market Size, 2018-2029
6.5.8 Nordic Countries Flu Vaccination Market Size, 2018-2029
6.5.9 Benelux Flu Vaccination Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Flu Vaccination Revenue, 2018-2029
6.6.2 By Region – Asia Flu Vaccination Sales, 2018-2029
6.6.3 China Flu Vaccination Market Size, 2018-2029
6.6.4 Japan Flu Vaccination Market Size, 2018-2029
6.6.5 South Korea Flu Vaccination Market Size, 2018-2029
6.6.6 Southeast Asia Flu Vaccination Market Size, 2018-2029
6.6.7 India Flu Vaccination Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Flu Vaccination Revenue, 2018-2029
6.7.2 By Country – South America Flu Vaccination Sales, 2018-2029
6.7.3 Brazil Flu Vaccination Market Size, 2018-2029
6.7.4 Argentina Flu Vaccination Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Flu Vaccination Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Flu Vaccination Sales, 2018-2029
6.8.3 Turkey Flu Vaccination Market Size, 2018-2029
6.8.4 Israel Flu Vaccination Market Size, 2018-2029
6.8.5 Saudi Arabia Flu Vaccination Market Size, 2018-2029
6.8.6 UAE Flu Vaccination Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Sanofi
7.1.1 Sanofi Company Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Flu Vaccination Major Product Offerings
7.1.4 Sanofi Flu Vaccination Sales and Revenue in Global (2018-2023)
7.1.5 Sanofi Key News & Latest Developments
7.2 CSL
7.2.1 CSL Company Summary
7.2.2 CSL Business Overview
7.2.3 CSL Flu Vaccination Major Product Offerings
7.2.4 CSL Flu Vaccination Sales and Revenue in Global (2018-2023)
7.2.5 CSL Key News & Latest Developments
7.3 GSK
7.3.1 GSK Company Summary
7.3.2 GSK Business Overview
7.3.3 GSK Flu Vaccination Major Product Offerings
7.3.4 GSK Flu Vaccination Sales and Revenue in Global (2018-2023)
7.3.5 GSK Key News & Latest Developments
7.4 Viatris
7.4.1 Viatris Company Summary
7.4.2 Viatris Business Overview
7.4.3 Viatris Flu Vaccination Major Product Offerings
7.4.4 Viatris Flu Vaccination Sales and Revenue in Global (2018-2023)
7.4.5 Viatris Key News & Latest Developments
7.5 AstraZeneca
7.5.1 AstraZeneca Company Summary
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca Flu Vaccination Major Product Offerings
7.5.4 AstraZeneca Flu Vaccination Sales and Revenue in Global (2018-2023)
7.5.5 AstraZeneca Key News & Latest Developments
7.6 Hualan Bio
7.6.1 Hualan Bio Company Summary
7.6.2 Hualan Bio Business Overview
7.6.3 Hualan Bio Flu Vaccination Major Product Offerings
7.6.4 Hualan Bio Flu Vaccination Sales and Revenue in Global (2018-2023)
7.6.5 Hualan Bio Key News & Latest Developments
7.7 Changchun Institute of Biological
7.7.1 Changchun Institute of Biological Company Summary
7.7.2 Changchun Institute of Biological Business Overview
7.7.3 Changchun Institute of Biological Flu Vaccination Major Product Offerings
7.7.4 Changchun Institute of Biological Flu Vaccination Sales and Revenue in Global (2018-2023)
7.7.5 Changchun Institute of Biological Key News & Latest Developments
7.8 Sinovac
7.8.1 Sinovac Company Summary
7.8.2 Sinovac Business Overview
7.8.3 Sinovac Flu Vaccination Major Product Offerings
7.8.4 Sinovac Flu Vaccination Sales and Revenue in Global (2018-2023)
7.8.5 Sinovac Key News & Latest Developments
7.9 BCHT
7.9.1 BCHT Company Summary
7.9.2 BCHT Business Overview
7.9.3 BCHT Flu Vaccination Major Product Offerings
7.9.4 BCHT Flu Vaccination Sales and Revenue in Global (2018-2023)
7.9.5 BCHT Key News & Latest Developments
7.10 Jiangsu GDK
7.10.1 Jiangsu GDK Company Summary
7.10.2 Jiangsu GDK Business Overview
7.10.3 Jiangsu GDK Flu Vaccination Major Product Offerings
7.10.4 Jiangsu GDK Flu Vaccination Sales and Revenue in Global (2018-2023)
7.10.5 Jiangsu GDK Key News & Latest Developments
7.11 KM Biologics
7.11.1 KM Biologics Company Summary
7.11.2 KM Biologics Flu Vaccination Business Overview
7.11.3 KM Biologics Flu Vaccination Major Product Offerings
7.11.4 KM Biologics Flu Vaccination Sales and Revenue in Global (2018-2023)
7.11.5 KM Biologics Key News & Latest Developments
8 Global Flu Vaccination Production Capacity, Analysis
8.1 Global Flu Vaccination Production Capacity, 2018-2029
8.2 Flu Vaccination Production Capacity of Key Manufacturers in Global Market
8.3 Global Flu Vaccination Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Flu Vaccination Supply Chain Analysis
10.1 Flu Vaccination Industry Value Chain
10.2 Flu Vaccination Upstream Market
10.3 Flu Vaccination Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Flu Vaccination Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Flu Vaccination in Global Market
Table 2. Top Flu Vaccination Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Flu Vaccination Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Flu Vaccination Revenue Share by Companies, 2018-2023
Table 5. Global Flu Vaccination Sales by Companies, (Units), 2018-2023
Table 6. Global Flu Vaccination Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Flu Vaccination Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Flu Vaccination Product Type
Table 9. List of Global Tier 1 Flu Vaccination Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Flu Vaccination Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Flu Vaccination Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Flu Vaccination Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Flu Vaccination Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Flu Vaccination Sales (Units), 2018-2023
Table 15. By Type - Global Flu Vaccination Sales (Units), 2024-2029
Table 16. By Application – Global Flu Vaccination Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Flu Vaccination Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Flu Vaccination Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Flu Vaccination Sales (Units), 2018-2023
Table 20. By Application - Global Flu Vaccination Sales (Units), 2024-2029
Table 21. By Region – Global Flu Vaccination Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Flu Vaccination Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Flu Vaccination Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Flu Vaccination Sales (Units), 2018-2023
Table 25. By Region - Global Flu Vaccination Sales (Units), 2024-2029
Table 26. By Country - North America Flu Vaccination Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Flu Vaccination Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Flu Vaccination Sales, (Units), 2018-2023
Table 29. By Country - North America Flu Vaccination Sales, (Units), 2024-2029
Table 30. By Country - Europe Flu Vaccination Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Flu Vaccination Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Flu Vaccination Sales, (Units), 2018-2023
Table 33. By Country - Europe Flu Vaccination Sales, (Units), 2024-2029
Table 34. By Region - Asia Flu Vaccination Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Flu Vaccination Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Flu Vaccination Sales, (Units), 2018-2023
Table 37. By Region - Asia Flu Vaccination Sales, (Units), 2024-2029
Table 38. By Country - South America Flu Vaccination Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Flu Vaccination Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Flu Vaccination Sales, (Units), 2018-2023
Table 41. By Country - South America Flu Vaccination Sales, (Units), 2024-2029
Table 42. By Country - Middle East & Africa Flu Vaccination Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Flu Vaccination Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Flu Vaccination Sales, (Units), 2018-2023
Table 45. By Country - Middle East & Africa Flu Vaccination Sales, (Units), 2024-2029
Table 46. Sanofi Company Summary
Table 47. Sanofi Flu Vaccination Product Offerings
Table 48. Sanofi Flu Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Sanofi Key News & Latest Developments
Table 50. CSL Company Summary
Table 51. CSL Flu Vaccination Product Offerings
Table 52. CSL Flu Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. CSL Key News & Latest Developments
Table 54. GSK Company Summary
Table 55. GSK Flu Vaccination Product Offerings
Table 56. GSK Flu Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. GSK Key News & Latest Developments
Table 58. Viatris Company Summary
Table 59. Viatris Flu Vaccination Product Offerings
Table 60. Viatris Flu Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Viatris Key News & Latest Developments
Table 62. AstraZeneca Company Summary
Table 63. AstraZeneca Flu Vaccination Product Offerings
Table 64. AstraZeneca Flu Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. AstraZeneca Key News & Latest Developments
Table 66. Hualan Bio Company Summary
Table 67. Hualan Bio Flu Vaccination Product Offerings
Table 68. Hualan Bio Flu Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Hualan Bio Key News & Latest Developments
Table 70. Changchun Institute of Biological Company Summary
Table 71. Changchun Institute of Biological Flu Vaccination Product Offerings
Table 72. Changchun Institute of Biological Flu Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Changchun Institute of Biological Key News & Latest Developments
Table 74. Sinovac Company Summary
Table 75. Sinovac Flu Vaccination Product Offerings
Table 76. Sinovac Flu Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Sinovac Key News & Latest Developments
Table 78. BCHT Company Summary
Table 79. BCHT Flu Vaccination Product Offerings
Table 80. BCHT Flu Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. BCHT Key News & Latest Developments
Table 82. Jiangsu GDK Company Summary
Table 83. Jiangsu GDK Flu Vaccination Product Offerings
Table 84. Jiangsu GDK Flu Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Jiangsu GDK Key News & Latest Developments
Table 86. KM Biologics Company Summary
Table 87. KM Biologics Flu Vaccination Product Offerings
Table 88. KM Biologics Flu Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. KM Biologics Key News & Latest Developments
Table 90. Flu Vaccination Production Capacity (Units) of Key Manufacturers in Global Market, 2021-2023 (Units)
Table 91. Global Flu Vaccination Capacity Market Share of Key Manufacturers, 2021-2023
Table 92. Global Flu Vaccination Production by Region, 2018-2023 (Units)
Table 93. Global Flu Vaccination Production by Region, 2024-2029 (Units)
Table 94. Flu Vaccination Market Opportunities & Trends in Global Market
Table 95. Flu Vaccination Market Drivers in Global Market
Table 96. Flu Vaccination Market Restraints in Global Market
Table 97. Flu Vaccination Raw Materials
Table 98. Flu Vaccination Raw Materials Suppliers in Global Market
Table 99. Typical Flu Vaccination Downstream
Table 100. Flu Vaccination Downstream Clients in Global Market
Table 101. Flu Vaccination Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Flu Vaccination Segment by Type in 2022
Figure 2. Flu Vaccination Segment by Application in 2022
Figure 3. Global Flu Vaccination Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Flu Vaccination Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Flu Vaccination Revenue, 2018-2029 (US$, Mn)
Figure 7. Flu Vaccination Sales in Global Market: 2018-2029 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Flu Vaccination Revenue in 2022
Figure 9. By Type - Global Flu Vaccination Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Flu Vaccination Revenue Market Share, 2018-2029
Figure 11. By Type - Global Flu Vaccination Sales Market Share, 2018-2029
Figure 12. By Type - Global Flu Vaccination Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Flu Vaccination Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Flu Vaccination Revenue Market Share, 2018-2029
Figure 15. By Application - Global Flu Vaccination Sales Market Share, 2018-2029
Figure 16. By Application - Global Flu Vaccination Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Flu Vaccination Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Flu Vaccination Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Flu Vaccination Revenue Market Share, 2018-2029
Figure 20. By Region - Global Flu Vaccination Sales Market Share, 2018-2029
Figure 21. By Country - North America Flu Vaccination Revenue Market Share, 2018-2029
Figure 22. By Country - North America Flu Vaccination Sales Market Share, 2018-2029
Figure 23. US Flu Vaccination Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Flu Vaccination Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Flu Vaccination Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Flu Vaccination Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Flu Vaccination Sales Market Share, 2018-2029
Figure 28. Germany Flu Vaccination Revenue, (US$, Mn), 2018-2029
Figure 29. France Flu Vaccination Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Flu Vaccination Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Flu Vaccination Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Flu Vaccination Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Flu Vaccination Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Flu Vaccination Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Flu Vaccination Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Flu Vaccination Sales Market Share, 2018-2029
Figure 37. China Flu Vaccination Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Flu Vaccination Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Flu Vaccination Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Flu Vaccination Revenue, (US$, Mn), 2018-2029
Figure 41. India Flu Vaccination Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Flu Vaccination Revenue Market Share, 2018-2029
Figure 43. By Country - South America Flu Vaccination Sales Market Share, 2018-2029
Figure 44. Brazil Flu Vaccination Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Flu Vaccination Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Flu Vaccination Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Flu Vaccination Sales Market Share, 2018-2029
Figure 48. Turkey Flu Vaccination Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Flu Vaccination Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Flu Vaccination Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Flu Vaccination Revenue, (US$, Mn), 2018-2029
Figure 52. Global Flu Vaccination Production Capacity (Units), 2018-2029
Figure 53. The Percentage of Production Flu Vaccination by Region, 2022 VS 2029
Figure 54. Flu Vaccination Industry Value Chain
Figure 55. Marketing Channels


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ インフルエンザ予防接種の世界市場見通し2023年-2029年(Flu Vaccination Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 肺炎球菌ワクチン接種の世界市場見通し2023年-2029年
  • 黄熱病予防接種の世界市場見通し2023年-2029年
  • 水痘ワクチン接種の世界市場見通し2023年-2029年
  • A型肝炎＆B型肝炎予防接種の世界市場見通し2023年-2029年
  • 百日咳ワクチン接種の世界市場見通し2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆